EP Patent

EP4622628A1 — Use of nano-carriers for delivery of active agents

Assigned to Landa Labs 2012 Ltd · Expires 2025-10-01 · 1y expired

What this patent protects

There are disclosed uses of compositions for the preparation of medications for the treatment of a subject or an object in need thereof, the compositions comprising nano-elements containing: a) at least one water-insoluble thermoplastic compound (WITC), capable of forming a core;…

USPTO Abstract

There are disclosed uses of compositions for the preparation of medications for the treatment of a subject or an object in need thereof, the compositions comprising nano-elements containing: a) at least one water-insoluble thermoplastic compound (WITC), capable of forming a core; and b) at least one active agent which can be disposed in said core or in shells surrounding the core. The nano-elements, having an average diameter in the sub-micron range, are constituted of materials having a low vapor pressure and are dispersible in a polar carrier. Methods for preparing these nano-elements, and administering them, so as to treat conditions corresponding to the active agents contained therein, are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP4622628A1
Jurisdiction
EP
Classification
Expires
2025-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Landa Labs 2012 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.